Stay updated with breaking news from Joseph Fiore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The new show at Wiscasset’s Maine Art Gallery (MAG) continues to explore the heritage that flows from the Gallery’s founding artists forward to today’s generation -- a theme that began with last year’s 65th anniversary exhibit, “Generations.” The...
The Food and Drug Administration will review Augtyro for potential approval in children and adults with advanced solid cancers that harbor NTRK gene fusions.
PRINCETON, N.J.--(BUSINESS WIRE)--Feb 14, 2024--
Repotrectinib is under priority review for patients with NTRK-positive locally advanced or metastatic solid tumors and high unmet medical need.
The FDA has accepted for Priority Review the sNDA for repotrectinib for the treatment of NTRK-positive locally advanced or metastatic solid tumors.